ORLANDO, Fla., Feb. 23, 2011 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), a leading provider of clinical information and
medication delivery technologies, today announced the unveiling of
the Hospira MedNet™ Portal at the Healthcare Information and
Management Systems Society (HIMSS) Annual Conference and Exhibition
in Orlando. This web-based
application will provide healthcare institutions with advanced
medication error reporting and patient safety benchmarking
capabilities. It will be available as an add-on feature to the
award-winning Hospira MedNet safety software.
Hospira MedNet Portal, on demonstration at HIMSS booth 6449,
improves a hospital's ability to monitor, benchmark and evaluate
intravenous (I.V.) drug administration practices. With this new
technology, healthcare institutions will have access to
side-by-side, blinded comparisons of their own safety software drug
libraries and infusion performance data with the same information
from other institutions. Users can look at data by hospital size,
institution type or specific clinical care areas to help them
develop and refine their drug library. The software system also
allows clinicians and hospital staff to view internal and external
peer benchmarking reports to drive improved I.V. medication safety
and to help enhance clinical and operational outcomes. Hospira
MedNet Portal supports continuous quality improvement efforts by
helping users analyze key aspects of their drug administration
process against best practices and by providing a more complete
picture of clinical performance indicators.
"Our hospital customers are telling us that they're not just
buying infusion pumps, they're also investing in the safety data
that comes from the infusion devices," said Richard Nevin, vice president, Medication
Management Systems, U.S., Hospira. "Hospira MedNet Portal will help
give every facility a better view of their medication
administration and safety performance, allowing them to benchmark
against how other institutions are practicing medicine, and driving
safety and continuous quality improvement programs."
Hospira MedNet Portal will be available as a value-added feature
for healthcare institutions using Hospira MedNet safety software
with their Hospira infusion technologies, such as the Plum A+™ with
Hospira MedNet safety software, a proven and scaleable infusion
pump system; the technologically advanced Symbiq™ infusion system
with built-in Hospira MedNet; and the market-leading LifeCare PCA™
pump with Hospira MedNet. Hospira is also the U.S. leader in I.V.
clinical integration of infusion pumps with electronic health
record systems.
The company is targeting mid-year for making Hospira MedNet
Portal available to Hospira MedNet customers.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and
medication delivery company dedicated to Advancing Wellness™. As
the world leader in specialty generic injectable pharmaceuticals,
Hospira offers one of the broadest portfolios of generic acute-care
and oncology injectables, as well as integrated infusion therapy
and medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake
Forest, Ill., and has approximately 14,000 employees. Learn
more at www.hospira.com.
Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the timing of availability of
the Hospira MedNet Portal to customers. Hospira cautions that these
forward-looking statements are subject to risks and uncertainties
that may cause actual results to differ materially from those
indicated in the forward-looking statements. Economic, competitive,
governmental, regulatory, legal, technological and other factors
that may affect Hospira's operations and may cause actual results
to be materially different from expectations include the risks,
uncertainties and factors discussed under the headings "Risk
Factors" and "Management's Discussion and Analysis of Financial
Condition and Results of Operations" in Hospira's latest Annual
Report on Form 10-K filed with the Securities and Exchange
Commission, which are incorporated by reference. Hospira undertakes
no obligation to release publicly any revisions to forward-looking
statements as the result of subsequent events or
developments.
SOURCE Hospira, Inc.